GlassScriptPhysician profile
Matthew S Slater
NPI 1487662912
$10,537.75
in general payments reported to CMS, 2019-2025
10 companies · $4,588 in 2025
The $4,588 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $559 · 2021: $964 · 2022: $988 · 2023: $1,877 · 2024: $597 · 2025: $4,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,800 · Food and Beverage: $2,788 · Consulting Fee: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,800.00 |
| Food and Beverage | $2,787.62 |
| Consulting Fee | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,675.49 | 2021-2025 | Corevalve Evolut R, Avalus, Simulus |
| Medtronic Vascular, INC. | $660.22 | 2019-2020 | |
| Abbott Laboratories | $659.54 | 2019-2023 | Amplatzer Talisman |
| Edwards Lifesciences Corporation | $563.54 | 2019-2025 | Pascal, Inspiris Resilia Aortic Valve |
| Abiomed | $272.46 | 2019-2021 | |
| Artivion, INC. | $251.37 | 2019-2023 | Cardiac Non-Synergraft, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive |
| Atricure, INC. | $164.00 | 2024 | |
| Boston Scientific Corporation | $159.89 | 2019-2022 | |
| Getinge USA Sales, LLC | $115.84 | 2019 | |
| Haemonetics Corporation | $15.40 | 2024 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Slater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.